05/18/2013 | Press Release

SurgLine International, Inc., a premiere reseller and distributor of FDA approved stable technology of surgical implants and surgical instruments in the operating room, has worked extensively alongside the MedPassage team to upload several thousand product SKU’s and anticipates the medpassage.com ecosystem launch shortly to its intended customer base.

The Company will offer its full line of products that it sells to ambulatory surgery centers and acute care hospitals through its affiliation with MedPassage at tremendous savings.

“The MedPassage ecosystem empowers medical centers and device companies to collaborate and exchange products more efficiently than ever before”, said Tom Toland, CEO of SurgLine International, Inc. “We are pleased to work alongside MedPassage and their talented executive management team and are anticipating a tremendous opportunity for SurgLine and its product offering.”

Over the past two months, the SurgLine team and the MedPassage team have worked work closely to upload SurgLine’s catalogs of FDA approved cost-effective surgical products onto the MedPassage ecosystem for sale to surgery centers, hospitals, ACO’s.

SurgLine and MedPassage anticipate tremendous future opportunities for both companies with its online strategy that both believe will change the way hospitals and surgery centers and ACO’s purchase surgical products in the future.

SurgLine is also working with its management team and auditors to file its overdue 10Q’s and will provide further updates on the status in upcoming updates to its shareholders.

About SurgLine, Inc.

SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospitals, self-insured employers and insurance companies.

About SurgLine International, Inc.

SurgLine International, Inc. is a holding company that, in addition to SurgLine, wholly owns Nuvo Solar Energy, Inc.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

For Further Information Contact:

Thomas Toland

949-698-8485